Intelligence Platform

Patents

Browse 2,465 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed

patent

US 6942663

Laser treatment of cutaneous vascular lesions

The Board of Regents of the University of Texas System · Granted Tue Sep 13 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 08 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6936639

Nitroxyl progenitors in the treatment of heart failure

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Aug 30 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 25 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6933274

Methods for treatment of diabetes using a peptide analogues of insulin

Neurocrine Biosciences, Inc. · Granted Tue Aug 23 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 18 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6933108

Methods and compositions for use in the treatment of filovirus mediated disease conditions

The Regents of the University of California · Granted Tue Aug 23 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 18 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6929802

Method of cancer treatment

The Board of Regents of the University of Texas System · Granted Tue Aug 16 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 11 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6924362

Monoclonal antibodies specific for the E2 glycoprotein of hepatitic C virus and their use

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Aug 02 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 28 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6911471

S-dimethylarsino-thiosuccinic acid s-dimethylarsino-2-thiobenzoic acid s-(dimethylarsino)

The Board of Regents of the University of Texas System · Granted Tue Jun 28 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 23 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6902743

Therapeutic treatment and prevention of infections with a bioactive material(s) encapuslat

The United States of America as represented by the Secretary of the Army · Granted Tue Jun 07 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 02 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6899880

Porin B (PorB) as a therapeutic target for prevention and treatment of infection by chlamy

The Regents of the University of California · Granted Tue May 31 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 26 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6896909

Formulations containing iron ores for the topical treatment of bioenergetic and electromag

WINMEDICAL S.R.L. · Granted Tue May 24 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 19 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6894026

Long-acting oxytocin analogues for the treatment and prevention of breast cancer and psych

Atossa Healthcare, Inc. · Granted Tue May 17 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 12 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6887862

Method for improving treatment selectivity and efficacy using intravascular photodynamic t

Miravant Systems, Inc. · Granted Tue May 03 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 28 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6881420

Compositions and dosage forms for gastric delivery of irinotecan and methods of treatment

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Apr 19 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 14 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6866845

Compositions and methods for the treatment of sepsis

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Mar 15 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 10 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6866844

Precursor N-acetylgalactosamine-4-sulfatase, methods of treatment using said enzyme and me

BIOMARIN PHARMACEUTICAL INC. · Granted Tue Mar 15 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 10 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6855340

Copper lowering treatment of inflammatory and fibrotic diseases

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Feb 15 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 10 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6849605

Inhibitors of serine protease activity, methods and compositions for treatment of viral in

The Regents of the University of Technology Office of Technology Transfer · Granted Tue Feb 01 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 27 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6844320

Treatment of preeclampsia, toxemia and preterm labor with combination of progestational ag

The Board of Regents of the University of Texas System · Granted Tue Jan 18 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 13 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6844010

Therapeutic treatment and prevention of infections with a bioactive materials encapsulated

The United States of America as represented by the Secretary of the Army · Granted Tue Jan 18 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 13 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6825323

Compositions for treatment of hemorrhaging with activated factor VIIa in combination with

The United States of America as represented by the Secretary of the Army · Granted Tue Nov 30 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 25 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6822071

Polypeptides from Chlamydia pneumoniae and their use in the diagnosis, prevention and trea

The Regents of the University of California · Granted Tue Nov 23 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 18 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6818213

Cancer treatment compositions comprising therapeutic conjugates that bind to aminophosphol

The Board of Regents of the University of Texas System · Granted Tue Nov 16 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 11 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6811775

Reovirus for the treatment of cellular proliferative disorders

ONCOLYTICS BIOTECH INC. · Granted Tue Nov 02 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 28 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6811782

Peptide composition as immunogen for the treatment of allergy

United Biomedical, Inc. · Granted Tue Nov 02 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 28 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired